ChartMill · Jul 20, 2026
Top movers in Monday's after hours session
After the conclusion of the US market's regular session on Monday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers.
NASDAQ · SHPH
Healthcare · Drug Manufacturers - Specialty & Generic
$4.58
Up+$0.35 (+8.27%)
Updated Aug 14, 2026, 9:25 AM
SID Score
5.8/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 21 trading sessions · Daily adjusted prices
SHPH closed at $4.58 after 21 trading sessions, up 29.01% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 13, 2026 | $4.19 | $4.80 | $4.19 | $4.58 | 94.7K |
| Aug 12, 2026 | $4.33 | $4.33 | $4.12 | $4.23 | 16.02K |
| Aug 11, 2026 | $4.06 | $4.32 | $3.9428 | $4.31 | 20.55K |
| Aug 10, 2026 | $4.21 | $4.21 | $3.8901 | $4.07 | 36.04K |
| Aug 7, 2026 | $4.51 | $4.5399 | $4.32 | $4.36 | 57.41K |
| Aug 6, 2026 | $4.29 | $4.51 | $4.06 | $4.38 | 82.61K |
| Aug 5, 2026 | $4.03 | $4.60 | $3.84 | $4.60 | 1.59M |
| Aug 4, 2026 | $3.37 | $3.65 | $3.2609 | $3.65 | 117.96K |
| Aug 3, 2026 | $3.36 | $3.5999 | $3.15 | $3.37 | 184.57K |
| Jul 31, 2026 | $3.03 | $4.40 | $2.92 | $3.80 | 3.07M |
| Jul 30, 2026 | $2.86 | $3.15 | $2.8001 | $3.09 | 201.13K |
| Jul 29, 2026 | $2.79 | $2.79 | $2.5764 | $2.78 | 207.38K |
| Jul 28, 2026 | $2.86 | $2.90 | $2.71 | $2.79 | 72.87K |
| Jul 27, 2026 | $2.86 | $2.93 | $2.78 | $2.92 | 125.16K |
| Jul 24, 2026 | $2.93 | $2.93 | $2.78 | $2.89 | 89.73K |
| Jul 23, 2026 | $3.00 | $3.04 | $2.90 | $2.99 | 113.66K |
| Jul 22, 2026 | $3.04 | $3.2499 | $3.01 | $3.06 | 130.95K |
| Jul 21, 2026 | $3.13 | $3.40 | $3.09 | $3.35 | 1.59M |
| Jul 20, 2026 | $3.18 | $3.21 | $2.96 | $3.03 | 3.1M |
| Jul 17, 2026 | $3.40 | $3.40 | $3.02 | $3.16 | 132.95K |
| Jul 16, 2026 | $3.56 | $3.70 | $3.3501 | $3.55 | 163.9K |
The latest Smart Investors Daily articles mentioning SHPH.
SHPH research
Company profile and research snapshot.
Shuttle Pharmaceuticals Holdings Inc is a clinical-stage pharmaceutical company leveraging its proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments with surgery, radiation therapy, chemotherapy and immunotherapy. Radiation therapy (RT) is one of the effective modalities for treating cancers. It is developing a pipeline of products designed to address the limitations of the current cancer therapies as well as to extend to the new applications of RT. The company believes that its product candidates will enable the company to deliver cancer treatments that are safer, more reliable and at a greater scale than that of the current standard of care.
Visit company websiteConsensus and target data currently published for this company.
No generated briefing is available yet.
ChartMill · Jul 20, 2026
After the conclusion of the US market's regular session on Monday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers.
Benzinga · Jul 20, 2026
Gainers Shuttle Pharmaceuticals (NASDAQ:SHPH) shares moved upwards by 25.1% to $3.79 during Monday's after-market session. The company's market cap stands at $1.8 million. China Pharma Holding (AMEX:CPHI)
Benzinga · Jul 15, 2026
Gainers Ernexa Therapeutics (NASDAQ:ERNA) stock increased by 88.3% to $11.41 during Wednesday's pre-market session. The market value of their outstanding shares is at $7.0 million. Catheter Precision (AMEX:VTAK)
ChartMill · Jul 14, 2026
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.


The latest Smart Investors Daily articles mentioning SHPH.